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Background: Falls are the most common cause of injuries and hospital admissions in the elderly. The Swedish
National Board of Health and Welfare has created a list of drugs considered to increase the fall risk (FRIDs) and
drugs that might cause/worsen orthostatism (ODs). This cross-sectional study was aimed to assess FRIDs and their
correlation with falls in a sample of 369 community-dwelling and nursing home patients aged ≥75 years and who
were using a multi-dose drug dispensing system.
Methods: Data were collected from the patients’ electronic medication lists. Retrospective data on reported falls
during the previous three months and severe falls during the previous 12 months were collected. Primary outcome
measures were incidence of falls as well as numbers of FRIDs and ODs in fallers and non-fallers.
Results: The studied sample had a high incidence of both reported falls (29%) and severe falls (17%). Patients were
dispensed a mean of 2.2 (SD 1.5) FRIDs and 2.0 (SD 1.6) ODs. Fallers used on average more FRIDs. Severe falls were
more common in nursing homes patients. More women than men experienced severe falls. There were positive
associations between number of FRIDs and the total number of drugs (p < 0.01), severe falls (p < 0.01) and female
sex (p = 0.03). There were also associations between number of ODs and both total number of drugs (p < 0.01) and
being community dwelling (p = 0.02). No association was found between number of ODs and severe falls.
Antidepressants and anxiolytics were the most frequently dispensed FRIDs.
Conclusions: Fallers had a higher number of FRIDs. Numbers of FRIDs and ODs were correlated with the total
number of drugs dispensed. Interventions to reduce falls in the elderly by focusing on reducing the total number
of drugs and withdrawal of psychotropic medications might improve the quality and safety of drug treatment in
primary care.
Keywords: Elderly, Falls, Prevention, Drug therapy, Fall risk-increasing drugsBackground
Drug prescribing in patients aged ≥75 years increased by
nearly 70% in Sweden between 1990 and 2010 [1]. A com-
prehensive Swedish register-based study showed that a high
number of drugs in elderly patients is related to a higher
risk of prescribing potentially inappropriate medications, as
well as higher risks of side-effects and drug-drug interac-
tions [2]. A meta-analysis of prospective studies indicated
that almost 17% of hospital admissions in the USA were* Correspondence: veronica.milos@med.lu.se
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reproduction in any medium, provided the orcaused by adverse drug reactions [3]. Meanwhile, both
Swedish and international studies have shown that a major-
ity of hospital admissions related to inappropriate drug use
could potentially be prevented [4].
Falls are the most common cause of injuries among pa-
tients older than 65 years. Seventy-three percent of hospital
admissions of patients older than 65 years are due to falls
[5]. Upper extremity fractures and hip fractures are the
most common fall-related injuries that lead to emergency
department visits [6]. A Swedish study showed that treat-
ment with fall risk-increasing drugs (FRIDs) was very com-
mon (93%) among older hip fracture patients both before
and after the fracture [7].
Today, there is a consensus definition of falls [8]. Several
risk assessment tools are available to assess a hospitalisedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Table 1 Fall risk-increasing drugs (FRIDs) and drugs that
may cause or worsen orthostatism (ODs) according to the
list from the Swedish National Board of Health and
Welfare (NBHW)
ATC* code Drugs/group of drugs
Increase the fall risk
NO2A Opioids
N05A (NO5AN excluded) Antipsychotics (lithium excluded)
N05B Anxiolytics
N05C Hypnotics and sedatives
N06A Antidepressants
May cause or worsen
orthostatism
C01D Vasodilators used in cardiac diseases
C02 Antihypertensives
C03 Diuretics
C07 Beta blocking agents
C08 Calcium channel blockers
C09 Renin-angiotensin system inhibitors
G04CA Alpha-adrenoreceptor antagonists
N04B Dopaminergic agents
N05A (NO5AN excluded) Antipsychotics (lithium excluded)
N06A Antidepressants
*Anatomical Therapeutic Chemical classification system.
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ing. The tools assess different clinical characteristics as
confusion, dizziness, cognitive impairment or adminis-
tered drugs. Although the causes of falls are multi-
factorial, medications are an important risk factor that it
might be possible to influence. The most common FRIDs
are different types of psychotropic drugs, such as seda-
tives, hypnotics, antidepressants and antipsychotic medi-
cations, which can cause sedation, impaired balance and
coordination. The use of selective serotonin reuptake in-
hibitors (SSRIs) has been associated with falls regardless of
the presence of depressive symptoms [13]. Due to age-
related physiological changes in blood pressure-regulating
systems and cardiovascular co-morbidity, cardiovascular
drugs may cause or worsen orthostatic hypotension and
falls [1,14,15]. Anti-Parkinson’s disease and dopaminergic
drugs might also increase the fall risk by causing or wors-
ening orthostatic hypotension, dyskinesia or hallucinations
[16]. Anticholinergic drugs, such as antihistamines and
urological spasmolytics, may affect elderly patients’ cogni-
tive skills and cause blurred vision, thereby increasing the
fall risk [16].
There is clear evidence that polypharmacy and the use
of psychotropic drugs, especially when combined with
cardiovascular medications or present as therapeutic du-
plications, increase the fall risk [16-19]. Medications for
night-time sedation, such as lorazepam and zopiclone,
have been found to be the most frequently prescribed
medications before a fall in general medicine inpatient
units in Canada [20].
A meta-analysis of interventions aiming to prevent
falls in the elderly showed that slow withdrawal of psy-
chotropics significantly reduced the risk of falling and
that prescribing modification programs for primary care
physicians significantly reduced risk of falling [21].
The National Board of Health and Welfare (NBHW)
in Sweden has produced a FRID list, and also a list of
drugs causing or worsening orthostatic blood pressure,
which is relevant for assessing the fall risk (Table 1) [1].
According to the Swedish Central Bureau of Statistics,
the proportion of the population 75 years or older was
9% in Sweden in 2012. Community-dwelling older adults
and nursing home residents in Sweden use on average
8–10 different drugs [1]. A large proportion of them use
the multi-dose drug dispensing (MDD) system. This sys-
tem involves machine-packaging all the medications that
the patient should take at any particular time together in
small labelled plastic bags. This packaging is done at a
regional pharmacy dispensing centre and means that
nurses are not involved in drug dosage preparation [22].
The use of the MDD system ensures a more reliable
source of a patient’s active medication list [23].
This study aimed to explore the association between
the drugs on the NBWH list of FRIDs and ODs and fallsin Swedish elderly community-dwelling and nursing home
patients.Methods
Patients and settings
Patients included in the study were users of the MDD
system [23], aged 75 years and older, living in nursing
homes or in their own homes with municipally provided
home care.
Patient data were collected from a separate rando-
mised controlled trial (RCT) examining whether multi-
professional drug reviews including a pharmacist could
improve the quality of pharmacotherapy among elderly
primary health care patients [24]. At baseline, nurses
completed a symptom checklist using the Pharmacother-
apeutical Symptom Evaluation 20 (PHASE-20) tool [25]
and sent the results to a pharmacist participating in the
study. PHASE-20 includes 20 questions and is designed
to identify drug-related symptoms (Additional file 1)
[25]. For this study, all intervention and control patients
from the aforementioned study [24] were included. In-
formation on baseline characteristics, such as age, sex,
residency, locomotion and blood pressure, was extracted
from the PHASE-20 responses.
The study received ethical approval from the Regional
Ethical Review Board in Lund (no. 2011/245).
Table 2 Baseline characteristics of the study sample
Characteristic Patient sample
Patients, N 369
Female, N (%) 280 (76)
Age (years), mean (SD) 87.4 (5.7)
Residency, N (%)
Nursing home 279 (76)
Community 90 (24)
Mean no. of drugs, N (SD) 11.8 (4.5)
No. of continuous drugs 9.5 (3.9)





Blood pressure (mmHg), mean (SD)
Systolic 130 (19.5)
Diastolic 70 (11.5)
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The patients were recruited to the RCT between September
1 and December 16 2011.
Data collection for the present study was conducted be-
tween September 1 2012 and February 15 2013. Baseline
drug lists were screened for FRIDs and ODs according to
the NBHW list. To facilitate the identification of FRIDs
and ODs, a list of all generic names and product names
was created. All identified drugs were classified according
to the Anatomical Therapeutic Chemical (ATC) classifica-
tion system [26]. Every drug was counted as one with its
unique ATC code regardless of the dosage or number of
pills for the individual patient. Data on FRIDs and ODs
were collected and analysed separately due to the distinc-
tion made by the NBHW and the fact that drugs from cer-
tain ATC groups (e.g. antipsychotics) appear on both the
FRID and OD lists.
The data for reported falls and severe falls were collected.
Reported falls were defined as falls during the past three
months reported by the nurse in the patient’s PHASE-20
checklist evaluation. Severe falls were defined as falls lead-
ing to emergency visits at hospitals or hospital admission as
a consequence of syncope, contusion or bone fracture dur-
ing the previous year as documented in the patient’s EMR.
Data on hospital admissions and hospital emergency visits
relating to falls during the year prior to inclusion in the
study were collected from the patient’s hospital electronic
medical records (EMRs).
Data analysis
Primary outcome measures were incidence of falls as well
as numbers of FRIDs and ODs in fallers and non-fallers.
The secondary outcome measure was distribution of drug
types among FRIDs and ODs. Data were analysed using
Student’s t-test and Fischer’s exact test for two-group com-
parisons, and multiple linear regression (backward method)
analyses. In the two regression analyses FRIDs and ODs
were used as the respective dependent variables while age,
gender, place of living, number of drugs and severe falls
were entered as independent variables. A significance level
of a = 0.05 was chosen. All data were analysed using IBM
SPSS version 20.0.
Results
Seventy-six percent of the 369 included patients were
women and the mean age was 87.4 (SD 5.7) years. A ma-
jority (76%) were living in nursing homes. Table 2 shows
the baseline data for the patients.
The patients were prescribed a mean of 2.2 (SD 1.5)
FRIDs according to the FRID list of the NBHW and 2.0
(SD 1.6) drugs from the OD list of the NBHW. Only
13% of the study sample had no drugs prescribed from
the FRID or OD lists. Data collected from the PHASE-
20 symptom checklist were available for all 369 patients.Almost four in ten patients experienced moderate to severe
dizziness, unsteadiness or fatigue. Data about reported falls
from the PHASE-20 assessment were only available for 275
patients (75%). Twenty-nine percent of these patients re-
ported at least one fall in the three months prior to the
PHASE-20 evaluation. More men reported falls during the
past three months. There were no differences between pa-
tients who reported falls and those who did not fall during
the past three months with regard to age, total number of
drugs and place of living (Table 3).
There were no significant differences between total
number of drugs, number of FRIDs, number of ODs or
blood pressure between community-dwelling and nurs-
ing home patients when performing a Student’s t-test.
Data for severe falls collected from the patients’ EMRs
were available for all 369 patients. Seventeen percent
had at least one severe fall during the previous year. Se-
vere falls were more common in nursing home patients
as compared to community-dwelling elderly patients.
More women experienced severe falls.
Two multiple linear analyses with number of FRIDs and
ODs as dependent variables were performed (Table 4).
They showed positive associations between the number of
FRIDs and the total number of prescribed drugs (p < 0.01)
and severe falls (p < 0.01). Being female was associated
with a higher number of FRIDs (p = 0.03). Associations
were found between the number of ODs and both the
total number of prescribed drugs (p < 0.01) and commu-
nity dwelling (p = 0.02). No association was found between
the number of ODs and the occurrence of severe falls.
Seventy-four different drugs were prescribed to pa-
tients among the total number of 1533 FRIDs. The five
Table 3 Comparisons between fallers and non-fallers regarding age, sex, place of living, number of drugs, FRIDs and ODs
Outcome variable Falls during the last 3 months
before the symptom evaluation
Falls leading to emergency visits or hospital
admissions during the last 12 months
Falls No falls P value Falls No falls P value
Sex, N (%)
Male 31 (44) 39 (56) <0.01* 4 (4) 85 (96) <0.01*
Female 50 (24) 155 (76) 58 (21) 222 (79)
Age, mean (SD) 87.2 (5.7) 87.2 (5.4) 0.97** 87.8 (5.6) 87.3 (5.7) 0.53**
Place of living, N (%)
Nursing home 53 (26) 149 (74) 0.07* 56 (20) 223 (80) <0.01*
Community 28 (38) 45 (62) 6 (7) 84 (93)
No. of drugs, mean (SD)
Total 11.5 (3.8) 11.8 (4.8) 0.58** 12.6 (4.4) 11.6 (4.5) 0.12**
Continuous use 9.5 (3.6) 9.2 (4.0) 0.64** 9.8 (3.5) 9.4 (3.9) 0.39**
As needed 2.0 (1.4) 2.5 (2.0) 0.01** 2.7 (2.1) 2.2 (1.6) 0.08**
No. of FRIDs1, mean (SD)
Total 2.4 (1.5) 2.0 (1.4) 0.06** 2.7 (0.7) 2.0 (0.6) <0.01**
Continuous use 2.0 (1.4) 1.6 (1.2) 0.02** 2.1 (1.4) 1.6 (1.3) <0.01**
As needed 0.4 (0.6) 0.5 (0.7) 0.41** 0.5 (0.7) 0.4 (0.6) 0.13**
No. of ODs2, mean (SD)
Total 1.8 (1.4) 2.0 (1.6) 0.26** 1.7 (1.5) 2.0 (1.5) 0.15**
Continuous use 1.6 (1.3) 1.7 (1.4) 0.38** 1.4 (1.2) 1.7 (1.3) 0.05**
As needed 0.2 (0.4) 0.2 (0.4) 0.28** 0.2 (0.4) 0.2 (0.4) 0.36**
*Fishers exact test.
**Student’s t-test.
1FRIDs = Fall risk-increasing drugs according to the NBHW.
2ODs = Drugs that may cause or worsen orthostatism according to the NBHW.
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ODs in the NBHW lists had the ATC codes N (Nervous
System) (54.1%) and C (Cardiovascular System) (45.6%).
The frequency and percentage of the different ATC groups
among prescribed FRIDs are presented in Table 5. For the
FRID list of the NBHW, the five most frequent prescri-
bed FRIDs were oxazepam (n = 151), citalopram (n = 113),
zopiclone (n = 104), mirtazapine (n = 68) and zolpidem
(n = 44).Table 4 Regression models with FRIDs and ODs as dependent
Dependent var
Model Unstandardised coefficients Stan
B Std. error
Female sex −0.340 0.162
No. of drugs 0.145 0.015
Severe falls 0.515 0.187
Dependent variable: ODs
No. of drugs 0.191 0.015
Severe falls −0.432 0.186
Community living 0.392 0.162Discussion
Main findings
Patients who had fallen were prescribed a higher number
of continuous-use FRIDs than patients with no reported
falls. A significant proportion (87%) of the study sample
was taking FRIDs and ODs, as in other studies [27]. More
men reported falls during the past three months; however,
more women suffered from severe falls leading to emer-
gency visits or hospital admission during the past year.variables
iable: FRIDs
dardised coefficients Sig. Model summary
Beta
−0.099 0.037 Adjusted R squared = 0.225
0.442 <0.001
0.130 0.006
0.542 <0.001 Adjusted R squared = 0.313
−0.102 0.152
0.106 0.016
Table 5 Frequency and percentage of ATC groups for
FRIDs and ODs according to NBHW lists
FRIDs
ATC*code Frequency %
N06A (Antidepressants) 238 29.4
N05B (Anxiolytics) 194 24.0
N05C (Hypnotics and sedatives) 187 23.1
N02A (Opioids) 142 17.5




C03 (Diuretics) 251 24.9
N06A (Antidepressants) 238 23.6
C01D (Vasodilators used in cardiac diseases) 136 13.5
C07 (Beta blocking agents) 129 12.8
C09 (Renin-angiotensin system inhibitors) 118 11.7
C08 (Calcium channel blockers) 64 6.3
N05A (Antipsychotics) 47 4.7
N04B (Dopaminergic agents) 22 2.2
G04CA (Alpha-adrenoreceptor antagonists) 4 0.4
C02 (Antihypertensives) 1 0.1
Total 1010 100
*Anatomical Therapeutic Chemical classification system.
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ported falls during the last three months (29%) and se-
vere falls (17%). The results are similar to previously
published results [28]. Data for reported falls during the
past three months might have included severe falls and
this explains the higher incidence of reported falls.
Fallers used a higher number of FRIDs, consistent with
the findings of similar studies [29]. It is difficult to com-
pare FRID data between different studies, since there are
several different FRID classifications. Other international
FRID lists include analgesics, hypoglycaemics and urin-
ary antispasmodics [30-32]. Since drugs from these clas-
ses were not included in the Swedish NBHW lists, our
results may differ from studies using more extensive
FRID and OD lists. We chose not to merge the FRID
and the OD lists from the NBHW but to present the re-
sults separately, because some drugs (e.g. antipsychotics)
are classified both as FRIDs and as ODs.
Female sex and residency in nursing homes were associ-
ated with severe falls. Due to low bone mass, the presence
of osteoporosis and low muscle strength, females are more
likely than males to experience a fall-related injury [33,34].
In our study, female sex was associated with a higher
number of FRIDs and this might explain the association
with severe falls. Nursing home patients have increased
care needs due to cognitive impairment, multiple illnessesand the use of a high number of drugs, and might there-
fore be more prone to fall. Numbers of FRIDs and ODs
were associated with the total number of drugs and with
severe falls. This is in agreement with previous studies
showing strong evidence of an association between the
use of psychoactive drugs and falls in the elderly [18], as
well as between polypharmacy and falls [10,35,36].
A majority of the patients were females, lived in nurs-
ing homes and had a high number of drugs, as in other
studies [37].
Antidepressants and anxiolytics were the most frequently
used FRIDs and have been previously found to predispose
elderly patients to falling [38]. The most frequently pre-
scribed FRID in the study sample was oxazepam. Due to
their muscle-relaxing effects, benzodiazepines have been as-
sociated with an increased risk of hip fractures in the eld-
erly [39]. Cardiovascular drugs such as the commonly
prescribed diuretic furosemide can cause or worsen ortho-
static hypotension. However, there was no association be-
tween the numbers of ODs and falls in this study.
Almost a third of the patients complaining of moder-
ate to severe symptoms of dizziness or unsteadiness re-
ported falling in the three months prior to the study,
compared to less than 10% of those who had no com-
plaints. This suggests that the PHASE-20 symptom
checklist might be a useful tool to predict falls among
elderly patients. One strength of this study is that the
drug lists are accurate and compliance with prescribed
drug therapy was high due to the use of the MDD sys-
tem. The reliability of the data is high since it was col-
lected in a standardized manner by a single individual.
The studied sample was from several different geo-
graphic regions in Skåne, Sweden, which increases the
generalizability of our results. PHASE-20 was found to
have acceptable consistency, test-retest reliability and
internal validity [25]. Nurses that used the symptom
checklist (PHASE-20) had direct contact with the pa-
tients, which ensured more accurate description of their
symptoms.
Limitations
A major limitation of the study is the cross-sectional de-
sign with collection of retrospective data about falls.
Since no risk assessment tool was used, we are unable to
stratify patients into low and high risk for falls. Data on
patients’ diagnoses were not collected. It is therefore
hard to draw a firm conclusion as to whether the cogni-
tive impairment itself or the treatment of its symptoms
is associated with falls.
Another major limitation of the study is also the lack
of geriatric assessment. The identification of cognitive
impairment, comorbidity and functional disability would
clarify the contribution of other potential factors in in-
creased fall risk.
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ber of FRIDs and ODs regardless of the defined daily dos-
age of each drug. More detailed drug information might
have provided better understanding of whether drug dos-
age affects fall risk.
All patients were included in the fall evaluation, even
though some of them were not ambulatory. This may
have caused some bias, since the chair-bound and bed-
bound patients were not able to walk freely and were
possibly less prone to falling.
Since the study is retrospective, it is not known what
each study patient’s drug profile was during the period
prior to the PHASE-20 evaluation.
Future research
Interventions to optimize drug therapy in elderly pa-
tients with an emphasis on preventing falls would need
to use a fall risk assessment tool including FRIDs to be
able to stratify the patients into low and high risk of fall-
ing. A prospective study design would also confirm the
strength of the association between exposure to FRIDs
and subsequent falls.
All our patients used the MDD system. Although this
system was originally developed to improve patient
safety and drug compliance among those with multiple
chronic co-morbidities, studies indicate that the use of
the MDD system may be associated with a higher num-
ber of drugs, especially psychotropics [40], and poorer
drug treatment. Future research should assess the pos-
sible effect of medication reviews with an emphasis on
FRIDs and falls as a method to increase the quality of
drug treatment in the elderly.
Conclusions
Falls were common in this study sample. Nursing home
patients and women had higher rates of falls requiring
emergency room visits or hospitalisations. The number of
FRIDs and ODs were associated with the total number of
drugs. Fallers had a higher number of FRIDs but there was
no association between number of ODs and falls. Antide-
pressants and anxiolytics were the most frequently used
FRIDs. Interventions to prevent falls in elderly patients
with a focus on reducing the total number of drugs and
withdrawing psychotropic medications might improve the
quality of drug treatment in elderly primary care patients.
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